Redhill Biopharma Ltd. - stock earnings
RDHL Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | 761000 USD | 1.8 million USD |
| 2023Q1 | 2.5 million USD | 12.8 million USD |
| 2022Q4 | 2.5 million USD | 12.8 million USD |
| 2022Q3 | -64.3 million USD | 17.6 million USD |
| 2022Q2 | -14.3 million USD | 18.3 million USD |
| 2022Q1 | -21.0 million USD | 18.2 million USD |
| 2021Q4 | -24.4 million USD | 22.1 million USD |
| 2021Q3 | -21.4 million USD | 21.6 million USD |
| 2021Q2 | -29.1 million USD | 21.5 million USD |
| 2021Q1 | -22.9 million USD | 20.6 million USD |
| 2020Q4 | -24.3 million USD | 21.5 million USD |
| 2020Q3 | -18.6 million USD | 20.9 million USD |
| 2020Q2 | -16.0 million USD | 20.9 million USD |
| 2020Q1 | -17.2 million USD | 1.1 million USD |
| 2019Q4 | -11.7 million USD | 1.6 million USD |
| 2019Q3 | -9.8 million USD | 1.4 million USD |
| 2019Q2 | -10.9 million USD | 1.6 million USD |
| 2019Q1 | -9.9 million USD | 1.7 million USD |
| 2018Q4 | -7.7 million USD | 1.4 million USD |
| 2018Q3 | -10.1 million USD | 2.2 million USD |
| 2018Q2 | -11.1 million USD | 2.4 million USD |
| 2018Q1 | -9.9 million USD | 2.4 million USD |
| 2017Q4 | -10.4 million USD | 2.0 million USD |
| 2017Q3 | -15.5 million USD | 1.5 million USD |
| 2017Q2 | -11.0 million USD | 483000 USD |
| 2017Q1 | -8.6 million USD | ? USD |
| 2016Q4 | -8.3 million USD | 100000 USD |
| 2016Q3 | -8.9 million USD | 1000 USD |
| 2016Q2 | -6.6 million USD | 1000 USD |
| 2016Q1 | -5.5 million USD | ? USD |
| 2015Q4 | -6.6 million USD | 2000 USD |
| 2015Q3 | -3.3 million USD | 1000 USD |
| 2015Q2 | -6.6 million USD | 1000 USD |
| 2015Q1 | -4.6 million USD | 1000 USD |
| 2014Q4 | -5.3 million USD | 1000 USD |
| 2014Q3 | -4.2 million USD | 4000 USD |
| 2014Q2 | -4.5 million USD | 4000 USD |
| 2014Q1 | 3.4 million USD | 7.0 million USD |
| 2013Q4 | -3.4 million USD | 1000 USD |
| 2013Q3 | -2.7 million USD | 3000 USD |
| 2013Q2 | -2.5 million USD | 4000 USD |
| 2013Q1 | -2.0 million USD | 4000 USD |
| 2012Q4 | -3.4 million USD | 4000 USD |
| 2012Q3 | -2.0 million USD | 3000 USD |
| 2012Q2 | -2.3 million USD | 5000 USD |
| 2012Q1 | -2.7 million USD | 4000 USD |
| 2011Q4 | -2.6 million USD | 3000 USD |
| 2011Q3 | -2.7 million USD | 11000 USD |
| 2011Q2 | ? USD | 3000 USD |
| 2011Q1 | ? USD | 6000 USD |
RDHL Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -59.2 million USD | 61.8 million USD |
| 2021 | -114.3 million USD | 85.8 million USD |
| 2020 | -89.0 million USD | 64.4 million USD |
| 2019 | -43.6 million USD | 6.3 million USD |
| 2018 | -38.8 million USD | 8.4 million USD |
| 2017 | -45.5 million USD | 4.0 million USD |
| 2016 | -29.4 million USD | 101000 USD |
| 2015 | -21.1 million USD | 3000 USD |
| 2014 | -10.7 million USD | 7.0 million USD |
| 2013 | -10.6 million USD | 12000 USD |
| 2012 | -10.3 million USD | 16000 USD |
| 2011 | -15.5 million USD | 23000 USD |
| 2010 | -2.5 million USD | ? USD |
RDHL
Price: $0.47
52 week price:
Earnings Per Share: 4.00 USD
P/E Ratio: -0.07
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 100.7 million
Ebitda: -13.8 millionMarket Capitalization: 14.4 million